Mesalazine
Mesalazine is a specialized aminosalicylate anti-inflammatory drug that works locally within the lower gastrointestinal tract rather than systemically. It targets the colonic mucosa to inhibit the synthesis of inflammatory leukotrienes and prostaglandins by downregulating cyclooxygenase (COX) and lipoxygenase (LOX) pathways in tissue macrophages. This precise, localized mechanism decreases structural mucosal swelling, scavenges toxic reactive oxygen species, and assists in achieving and maintaining clinical remission in inflammatory conditions of the colon.
Reduces Bowel Inflammation
Relieves Abdominal Pain
Supports Ulcerative Colitis Treatment
Reduces Bowel Inflammation
Relieves Abdominal Pain
Supports Ulcerative Colitis Treatment
High Purity & Efficacy
USP / BP / EP / IP Grade Compliance
Stringent Quality Control & Batch Consistency
Pharmaceutical Formulations
Oral Solid Dosage (Tablets & Capsules)
Sterile Formulations / Injectables (where applicable)
Custom API Compounding